Risk for developing psoriasis significantly increased for NAFLD patients, and risk for NAFLD significantly increased for psoriasis patients

About fourfold and sixfold increases in melanoma incidence seen in White women and men from 1975 to 2014, while much smaller increases seen in...

During a 24-month period in a real-world setting, persistence and adherence higher with ixekizumab versus secukinumab for plaque psoriasis

Strongest evidence of association with reduced risk for measures related to school closures, reduced time spent in nonresidential areas

No improvement seen in prediction of CV events using expanded model with cardiac biomarkers and Framingham Risk Score

Physician, nonphysician health professionals, and other videos were all of higher quality than patient videos

Efficacy maintained at 52 weeks, with acceptable safety profile, for adolescents, adults with moderate-to-severe atopic dermatitis

Most elevated risks seen for cancers associated with viruses; male sex, older age, UV radiation exposure also linked to increased risk for cancers

From 2017 to 2019, increase seen in use of adjuvant systemic therapy, with variation in use among treating centers

Valuation of debt instruments significantly decreased from May to August 2019, followed by further decrease during COVID-19

The lithium-ion battery in the Ionic smartwatch can overheat and cause burns

Both devices safe and effective, with low VAS pain scores and high preinjection and postinjection Self-Injection Assessment Questionnaire scores

Acne Scar Assessment Scale value significantly improved in split-face study of atrophic postacne scars with both treatments

Risk for severe acne lower for atopic dermatitis patients than controls, with the reduced risk driven by adolescents, young adults

For those with adult acne, atopic dermatitis, psoriasis, the more severe the condition, the higher the perceived stress scores

Limited evidence suggests that continuing biological DMARDs may lower risk for disease flares without increasing risk for postop complications

Body mass index ≥25 kg/m

Five-year recurrence rate about 40 percent; 95 percent of recurrences occurred within first three years

Odds of BDD increased more than 11-fold for patients with hyperhidrosis, alopecia, and vitiligo versus healthy-skin control

No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers

Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenation

There have been no reports of adverse events related to the recall, which is being conducted out of an 'abundance of caution'

Variables in the model include age at onset, duration, nail involvement, erythematous lunula, onychorrhexis, oil drop, subungual hyperkeratosis